Skip to content
← Full study record

NCT00901225 · OUTCOME

Platelet Engraftment

Study of Plerixafor for Rescue of Poor Mobilizers in Autologous Stem Cell Transplant · Source last updated 2014-05-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
days
Interval / dispersion
Full Range
Time frame
12 months

What was measured

Days to platelet count \>20,000

Groups in this outcome

G-CSF Plus Plerixafor

Patients who were unable to mobilize a minimum number of cells (CD34+ cell count \<20 cells/ul)following 5 days of G-CSF mobilization.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
G-CSF Plus Plerixafor20

Reported measurements

Source class 1
Values in days · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
G-CSF Plus Plerixafor19Not reported1044Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        10
        upper Limit
        44
        value
        19
denoms
  1. counts
    1. group Id
      OG000
      value
      20
    units
    Participants
description
Days to platelet count \>20,000
dispersion Type
Full Range
groups
  1. description
    Patients who were unable to mobilize a minimum number of cells (CD34+ cell count \<20 cells/ul)following 5 days of G-CSF mobilization.
    id
    OG000
    title
    G-CSF Plus Plerixafor
param Type
MEDIAN
reporting Status
POSTED
time Frame
12 months
title
Platelet Engraftment
type
SECONDARY
unit Of Measure
days

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice